No Data
No Data
Fudan Zhangjiang (01349.HK) was reduced by 364,000 shares by Invesco Hong Kong
Glonghui, May 13 | According to the Stock Exchange's latest equity disclosure data, on May 8, 2024, Fudan Zhangjiang (01349.HK) was reduced by 364,000 shares by Invesco Hong Kong Limited at an average price of HK$2.1664 per share, involving approximately HK$78,600. After reducing its holdings, Invesco Hong Kong Limited's latest shareholding was 16.16 million shares, and the shareholding ratio dropped from 5.06% to 4.95%.
Fudan Zhangjiang (01349) plans to use no more than 250 million yuan of temporarily idle funds raised for cash management
Fudan Zhangjiang (01349) issued an announcement. The company will hold the 6th meeting of the 8th board of directors on April 29, 2024...
Fudan Zhangjiang (01349.HK): Net profit of 2,347,400 yuan in the first quarter decreased by 73.29% year-on-year
Gelonghui, April 29 | Fudan Zhangjiang (01349.HK) announced that in the first quarter of 2024, it achieved operating income of 147 million yuan, a year-on-year decrease of 21.94%; net profit attributable to shareholders of listed companies was 2,347,400 yuan, a year-on-year decrease of 73.29%.
復旦張江:截至二零二四年三月三十一止三個月期間第一季度業績公告
復旦張江:二零二三年度報告
Shanghai Fudan-Zhangjiang Buys Structured Deposits Worth 200 Million Yuan
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) has bought structured deposit products worth 200 million yuan from the Shanghai Pudong Development Bank (SHA:600000) this month, according to Mo
No Data